Showing results (281-290 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|September 8, 2000
Mirtazapine. A pharmacoeconomic review of its use in depressionK J Holm, B Jarvis, R H FosterPharmacoeconomics|September 8, 2000
Costs for acute myocardial infarction in a tertiary care centre and nationwide in FranceO Montagne, C Chaix, A Harf, et al.Pharmacoeconomics|September 8, 2000
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in AustraliaJ A Mauskopf, S C Cates, A D Griffin, et al.Pharmacoeconomics|September 8, 2000
Cost of illness in adult patients with hypopituitarismC Ehrnborg, L Hakkaart-Van Roijen, B Jonsson, et al.Pharmacoeconomics|January 9, 2001
The need for an iterative process for assessing economic outcomes associated with SSRIsT L Skaer, D A Sclar, L M Robison, et al.Pharmacoeconomics|January 9, 2001
Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practiceJ A Mauskopf, A Richter, L Annemans, et al.Pharmacoeconomics|March 31, 2001
The burden of arthritis and nonsteroidal anti-inflammatory treatment. A European literature reviewE Hunsche, J V Chancellor, N BrucePharmacoeconomics|March 31, 2001
A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritisT A Burke, R A Zabinski, D Pettitt, et al.Pharmacoeconomics|January 11, 2001
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?R D Hays, J M WoolleyPharmacoeconomics|March 3, 2001
Effectiveness of eletriptan in reducing time loss caused by migraine attacksN E Wells, T J SteinerPageof 335